Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 130, Issue 1, 2007, Pages 99-106

  Gomes, Mariana K O ^a   Vieira, Carolina S ^a   Moura, Marcos D ^a   Manetta, Luiz A ^a   Leite, Stael P ^a   Reis, Rosana M ^a   Ferriani, Rui A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Human chorionic gonadotropin; Human menopausal gonadotropin; Luteinizing hormone; Ovulation induction; Recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL;

EID: 33845520817     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.05.025     Document Type: Article

References (31)

1. Balasch J., and Fábregues F. Is luteinizing hormone needed for optimal ovulation induction?. Curr Opin Obstet Gynecol 4 (2002) 265-274
2. Filicori M., Cognigni G.E., Samara A., et al. The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Hum Reprod Update 8 (2002) 543-557
3. Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 77 (2002) 1170-1177
4. Zeleznik A.J. Follicle selection in primates: "many are called but few are chosen". Biol Reprod 65 (2001) 655-659
5. Chappel S.C., and Howles C. Reevaluation of the roles of luteinizing hormones and follicle-stimulating hormone in the ovulatory process. Hum Reprod 6 (1991) 1206-1212
6. Patrizio P., Esposito M., and Barnhart K. Low mean LH concentrations in the late follicular phase of IVF cycles down regulated with low dose luteal GnRHa and stimulated with recombinant FSF (Gonal F) affect fertilization rates. Program of the 1999 annual meeting of the American Society for Reproductive Medicine. Toronto, Canada (1999) S89
7. Westergaard L.G., Laursen S.B., and Andersen C.Y. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 15 (2000) 1003-1008
8. Filicori M., Cognigni G.E., Taraborrelli S., Spettoli D., Ciampaglia W., and Tabarelli de Fatiz C. Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertil Steril 72 (1999) 1118-1120
9. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 83 (1998) 1507-1514
10. Arguinzoniz M., Duerr-Myers L., Engrand P., Piazzi A., and Loumaye E. The efficacy and safety of recombinant human luteinizing hormone for minimizing the number of pre-ovulatory follicles in WHO group I anovulatory women treated with rhFSH. Program of the 15th annual meeting of the European Society of Human Reproduction and Embryology. Bologna, Italy (2000) 70-71
11. Loumaye E., Duerr-Myers L., Engrand P., Piazzi A., and Arguinzoniz M. Minimizing the number of pre-ovulatory follicles in WHO group II anovulatory women over-responding to FSH with recombinant human luteinizing hormone. Program of the 15th annual meeting of the European Society of Human Reproduction and Embryology. Bologna, Italy (2000) 71
12. Sullivan M.W., Stewart-Akers A., Krasnow J.S., Berga S.L., and Zeleznik A.J. Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation. J Clin Endocrinol Metab 84 (1999) 228-232
13. Filicori M., Cognigni G.E., Tabarelli C., et al. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 87 (2002) 1156-1161
14. Navot D., Relou A., Birkenfeld A., Rabinowitz R., Brzezinski A., and Margalioth E.J. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 159 (1988) 210-215
15. Filicori M., Cognigni G.E., Taraborrelli S., Parmegiani L., Bernardi S., and Ciampaglia W. Intracytoplasmic sperm injection pregnancy after low dose human chorionic gonadotropin alone to support ovarian folliculogenesis. Fertil Steril 78 (2002) 414-416
16. Filicori M., Cognigni G.E., Gamberini E., Parmegiani L., Troilo E., and Roset B. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 84 (2005) 394-401
17. Stockman P.G., de Leeuw R., van den Wijngaard H.A., Kloosterboer H.J., Vemer H.M., and Sander A.L. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil Steril 60 (1993) 175-180
18. Agrawal R., Holmes J., and Jacobs H.S. Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis. Fertil Steril 73 (2000) 338-343
19. Ng E.H.Y., Lau E.Y.L., Yeung W.S.B., and Ho P.C. HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial. Hum Reprod 16 (2001) 319-325
20. The European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone. Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial. Fertil Steril 78 (2002) 520-528
21. Kilani Z., Dakkak A., Ghunaim S., et al. A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes. Hum Reprod 18 (2003) 1194-1199
22. Lee K.L., Couchman G.M., and Walmer D.K. Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation. J Assist Reprod Gen 22 (2005) 37-40
23. Branigan E.F., and Estes A. Use of micro-dose human chorionic gonadotropin (hCG) after clomiphene citrate (CC) to complete folliculogenesis in previous CC-resistant anovulation. Am J Obstet Gynecol 192 (2005) 1890-1896
24. Tesarik J., and Mendonza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod 17 (2002) 3129-3137
25. Filicori M., Cognigni G.E., Parmegiani L., et al. Efficacy of low-dose hCG in ovarian stimulation. Abstracts of the 20th annual meeting of the ESHRE (2004) i119-i120
26. Hazout A., Junca A.M., and Bacrie P.C. FSH coasting combined with recombinant LH: a novel stimulation approach for ART. Fertil Steril 80 (2003) S8
27. Ubaldi F., Camus M., Smitz J., Bennink H.C., Van Steirteghem A., and Devroey P. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril 66 (1996) 275-280
28. Shulman A., Ghetler Y., Beyth Y., and Ben-Nun I. The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a "long protocol" of gonadotropin releasing hormone analogue and human menopausal gonadotropins. J Assist Reprod Gen 13 (1996) 207-211
29. Hofmann G.E., Khoury J., Jonhson C.A., Thie J., and Scott Jr. R.T. Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome. Fertil Steril 66 (1996) 980-988
30. Legro R.S., Ary B.A., Paulson R.J., Stanczyk F.Z., and Sauer M.V. Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in vitro fertilization. Hum Reprod 8 (1993) 1506-1511
31. Martinez F, Coroleu B, Clua E, et al. Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles. Reprod Biomed Online 2003;8:183-90.